Lactoperoxidase

The healthy oral cavity contains no antiseptic — it has something smarter. The lactoperoxidase enzyme system generates reactive antibacterial molecules at the moment of bacterial threat, using substrates that are harmless on their own. This is not a "chemical attack" but a "smart weapon" of innate immunity that activates precisely when needed.

What It Is

Lactoperoxidase (LPO, EC 1.11.1.7) is a haemoprotein enzyme of the peroxidase family, molecular weight ~78 kDa, containing one iron atom in a haem cofactor. In the oral cavity it is secreted primarily by the parotid, submandibular, and minor labial salivary glands. In healthy whole saliva, LPO concentration is 0.5–5 µg/mL.

The critical distinction from lysozyme and lactoferrin: lactoperoxidase does not act alone. It operates only as part of the three-component LP system:

1. Lactoperoxidase (enzyme catalyst)
2. Thiocyanate (SCN⁻) — substrate (salivary concentration: 0.5–4 mM, influenced by diet, smoking, cruciferous vegetable intake)
3. Hydrogen peroxide (H₂O₂) — oxidant (generated in saliva by aerobic streptococci and catalase)

How It Works

The central LP system reaction:

LPO + H₂O₂ + 2 SCN⁻ → LPO (oxidised) + 2 OSCN⁻ (hypothiocyanite) + 2 H₂O

Hypothiocyanite (OSCN⁻) is the final antibacterial agent. It is a powerful oxidant that targets sulphydryl (-SH) groups in bacterial proteins and enzymes. Oxidation of thiol groups in key bacterial enzymes (glyceraldehyde-3-phosphate dehydrogenase, pyruvate kinase) irreversibly disrupts bacterial metabolism.

OSCN⁻ advantages over chlorhexidine:

• Hypothiocyanite is not a non-selective oxidant — it reacts preferentially with pathogen thiol groups without attacking collagen, epithelial DNA, or salivary proteins (which have few free -SH groups)
• It does not accumulate and is rapidly inactivated in host tissues
• Does not cause tooth staining or dysbiosis with long-term use — unlike chlorhexidine

Specificity to cariogenic pathogens. Streptococcus mutans is a highly acidogenic organism that produces significant H₂O₂ during aerobic growth. This means it self-activates the LP system against itself: the more actively S. mutans generates H₂O₂, the more OSCN⁻ is produced, suppressing its own metabolism.

Efficacy

Classic SCN⁻ + LP study (PMID: 6945461)

Tenovuo & Mansson-Rahemtulla (1981): in the presence of thiocyanate and H₂O₂, lactoperoxidase inhibited S. mutans growth at concentrations fully consistent with physiological levels in saliva. Inhibition increased with higher SCN⁻ concentrations (0.5–2 mM). This is the foundational evidence that the LP system functions as a self-regenerating antibacterial barrier.

Clinical RCT with mouthwash (PMID: 19680511)

Gulsahi et al. (2009): 40 adults, 2-week course of an alcohol-free LP-system mouthwash versus control. Salivary S. mutans levels dropped significantly in the LP group. Lactobacilli (another caries risk marker) were also reduced. Importantly, the absence of alcohol allowed use in dry-mouth patients without irritation.

Clinical enzyme complex for xerostomia (PMID: 11999007)

Tenovuo (2002): overall assessment of clinical trials of the triple complex LP + lysozyme + lactoferrin in xerostomia patients showed improvement in 70–80% compared to controls. The LP component provides active antibacterial defence, while lysozyme and lactoferrin work through independent mechanisms.

Airway mucosal defence (PMID: 12606820)

Wijkstrom-Frei et al. (2003): the LP system is part of mucosal immunity not only in the mouth but also in the lungs. This broader concept explains why enzyme-based pastes reduce respiratory infection frequency in xerostomia patients.

Safety

Lactoperoxidase is a native human enzyme found in many mammals. It is industrially sourced from cow's milk (dairy whey).

• Listed in EU CosIng without concentration restrictions
• GRAS status (FDA)
• Non-toxic, non-mutagenic, non-photosensitising
• OSCN⁻ — the reaction product — is unstable and is rapidly reduced back to SCN⁻ in host tissues, with no accumulation
• Key manufacturing constraint: compatibility with an H₂O₂ source in the formulation. Glucose + glucose oxidase (GOx) is commonly used for slow in-situ H₂O₂ generation

Role in the QDRO Formula

Lactoperoxidase is the "engine" of the QDRO triple enzyme system. Without an H₂O₂ source in the formula, its activity is minimal, so the formulation must include one of two options:

1. Glucose + glucose oxidase — slow H₂O₂ generation from salivary glucose (preferred for toothpastes)
2. Low-concentration H₂O₂ (0.04–0.1%) — rapid reaction onset (for mouthwashes)

LPO concentration: 0.02–0.05% in toothpaste, up to 0.1% in mouthwash.

Brand verdict: we use it — the "brain" of the QDRO enzyme system, the key antibacterial mechanism without synthetic antiseptics.

---

Sources:

• Tenovuo J. (2002). Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia. Oral Dis. PMID: 11999007
• Kussendrager KD, van Hooijdonk AC. (2000). Lactoperoxidase: physicochemical properties, occurrence, mechanism of action and applications. Br J Nutr. PMID: 10902985
• Tenovuo J, Mansson-Rahemtulla B. (1981). Peroxidase and thiocyanate in human whole saliva. Arch Oral Biol. PMID: 6945461
• Gulsahi K et al. (2009). Effect of a non-alcohol based mouthrinse containing the lactoperoxidase system on S. mutans and lactobacilli in saliva. Eur J Dent. PMID: 19680511
• Wijkstrom-Frei C et al. (2003). Lactoperoxidase and human airway host defense. Am J Respir Cell Mol Biol. PMID: 12606820